A Study of miRNA 371 in Patients with Germ Cell Tumors
A Study of miRNA 371 in Patients with Germ Cell Tumors
This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.
Urologic
N/A
Adults
Not Available
Not Available
Rini, Brian
International
Vanderbilt University
10-09-2020
Eligibility
18 Years
BOTH
NO